Skip to content

Efficacy and safety of paracetamol nerve block combined with TAPB nerve block in elderly patients undergoing gastrointestinal surgery

Efficacy and safety of paracetamol mannitol injection combined with TAPB nerve block in elderly patients undergoing gastrointestinal surgery

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400079358
Enrollment
Unknown
Registered
2024-01-02
Start date
2024-01-02
Completion date
Unknown
Last updated
2024-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stomach cancer

Interventions

Experimental group (paracetamol mannitol injection + TAPB nerve block group):Thirty minutes before induction of anesthesia, TAPB nerve block was performed under the guidance of ultrasound and 1 g of p
Control Group (Sufentanil and TAPB nerve block group):Thirty minutes before anesthesia induction, TAPB nerve block was performed under the guidance of ultrasound. At the same time, 0.9% normal saline
Control Group (Sufentanil Group):General induction anesthesia was performed and 0.9% normal saline (100ml) was given intravenously

Sponsors

Deyang People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
65 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1 Age =65 years, 18.5 < BMI < 28; 2 Asa Grade I, II, III patients undergoing elective abdominal surgery (including radical gastrectomy, radical colon surgery, radical rectum surgery) ; 3 Understanding of the study flow, can operate PCIA (patient-controlled analgesia) equipment, can communicate effectively with researchers; 4 Volunteer and sign informed consent; 5 The operation time was within 4 hours.

Exclusion criteria

Exclusion criteria: 1 A patient who is allergic to the active paracetamol or any of its components; 2 An active bleeding or a high bleeding tendency; 3 Poorly controlled or untreated hypertension (arterial hypertension, resting systolic/diastolic blood pressure over 180/100 mmhg); 4 Untreated or undertreated hyperthyroidism; 5 Those who needed other operations during the same period or had complications that affected the evaluation of the study; 6 Those who were informed and did not want to participate in the study; 7 Post-op intensive-care unit; 8 Patients who have or have had a history of severe mental disorders; 9 Heart failure, previous history of severe angina, history of unstable angina or myocardial infarction in the past six months; 10 Before the study, each patient was tested with visual analogue scale (Vas) , patient-controlled analgesia (PCA) pump operation, answering telephone and understanding of neuropathic pain syndrome scale (NPSI) , patients who did not meet these criteria were excluded from the study; 11 Participants in other clinical trials within the last 3 months; 12 Patients who were on long-term pain medication, or who had used pain medication 7 days before surgery.

Design outcomes

Primary

MeasureTime frame
Pain score;vital signs;Postoperative delirium;Numeric Rating Scale,NRS;Brief Pain Inventory,BPI;

Secondary

MeasureTime frame
Basic information;

Countries

China

Contacts

Public Contactzhi fu zhao

Deyang People's Hospital

458018084@qq.com+86 135 5024 7650

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026